Seroprevalence of Pertussis in Adults at Childbearing Age Pre- and Post- COVID-19 in Beijing, China
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Subjects and Serum Samples
2.2. Serological Testing
2.3. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Appendix A
References
- Hu, C.; Tang, Y.; Su, Q.; Lei, Y.; Cui, W.; Zhang, Y.; Zhou, Y.; Li, X.; Wang, Z.; Zhao, Z. Public Health Measures During the COVID-19 Pandemic Reduce the Spread of Other Respiratory Infectious Diseases. Front. Public Health 2021, 9, 771638. [Google Scholar] [CrossRef] [PubMed]
- Huh, K.; Jung, J.; Hong, J.; Kim, M.; Ahn, J.G.; Kim, J.H.; Kang, J.M. Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study. Clin. Infect. Dis. 2021, 72, e184–e191. [Google Scholar] [CrossRef] [PubMed]
- Park, S.; Michelow, I.C.; Choe, Y.J. Shifting Patterns of Respiratory Virus Activity Following Social Distancing Measures for Coronavirus Disease 2019 in South Korea. J. Infect. Dis. 2021, 224, 1900–1906. [Google Scholar] [CrossRef] [PubMed]
- Sakamoto, H.; Ishikane, M.; Ueda, P. Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan. JAMA 2020, 323, 1969–1971. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Soo, R.J.J.; Chiew, C.J.; Ma, S.; Pung, R.; Lee, V. Decreased Influenza Incidence under COVID-19 Control Measures, Singapore. Emerg. Infect. Dis. 2020, 26, 1933–1935. [Google Scholar] [CrossRef]
- Feng, L.; Zhang, T.; Wang, Q.; Xie, Y.; Peng, Z.; Zheng, J.; Qin, Y.; Zhang, M.; Lai, S.; Wang, D.; et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat. Commun. 2021, 12, 3249. [Google Scholar] [CrossRef] [PubMed]
- Falkenstein-Hagander, K.; Appelqvist, E.; Cavefors, A.F.; Källberg, H.; Nilsson, L.J.; Silfverdal, S.A.; Storsaeter, J.; Aronsson, B. Waning infant pertussis during COVID-19 pandemic. Arch. Dis. Child 2022, 107, e19. [Google Scholar] [CrossRef]
- Tessier, E.; Campbell, H.; Ribeiro, S.; Rai, Y.; Burton, S.; Roy, P.; Fry, N.K.; Litt, D.; Amirthalingam, G. Impact of the COVID-19 pandemic on Bordetella pertussis infections in England. BMC Public Health 2022, 22, 405. [Google Scholar] [CrossRef] [PubMed]
- Di Mattia, G.; Nicolai, A.; Frassanito, A.; Petrarca, L.; Nenna, R.; Midulla, F. Pertussis: New preventive strategies for an old disease. Paediatr. Respir. Rev. 2019, 29, 68–73. [Google Scholar] [CrossRef]
- National Health Commission of the People’s Republic of China. Epidemic Situations of Legal Infectious Diseases in China. Available online: http://www.nhc.gov.cn/jkj/s7923/202108/7337fd75c8b749309a2de28aec1a03bd.shtml (accessed on 4 April 2022).
- World Health Organization. Immunization data: Comparison of Immunization Coverage for Diphtheria Tetanus Toxoid and Pertussis (DTP) Vaccination Coverage and Reported Cases for Pertussis. Available online: https://immunizationdata.who.int/compare.html?COMPARISON=type1__WIISE/MT_AD_COV_LONG+type2__WIISE/MT_AD_INC_LONG+option1__DTP_coverage+option2__PERTUSSIS_cases&CODE=CHN&YEAR= (accessed on 4 April 2022).
- The Data-Center of China Public Health Science. Notifiable Infectious Diseases: Pertussis. Available online: https://www.phsciencedata.cn/Share/ky_sjml.jsp?id=09163f05-0e42-4e24-a524-dc6ddf8206ac (accessed on 4 April 2022).
- Chen, Z.; Zhang, J.; Cao, L.; Zhang, N.; Zhu, J.; Ping, G.; Zhao, J.; Li, S.; He, Q. Seroprevalence of pertussis among adults in China where whole cell vaccines have been used for 50 years. J. Infect. 2016, 73, 38–44. [Google Scholar] [CrossRef]
- Zhang, Q.; Zheng, H.; Liu, M.; Han, K.; Shu, J.; Wu, C.; Xu, N.; He, Q.; Luo, H. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: A cross sectional study. BMC Infect. Dis. 2012, 12, 138. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Chen, M.; Zhang, T.; Li, J.; Zeng, Y.; Lu, L. Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study. Hum. Vaccin. Immunother. 2015, 11, 2434–2439. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xu, Y.; Wang, L.; Xu, J.; Wang, X.; Wei, C.; Luo, P.; Ma, X.; Hou, Q.; Wang, J. Seroprevalence of pertussis in China: Need to improve vaccination strategies. Hum. Vaccin. Immunother. 2014, 10, 192–198. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- He, H.; Yao, P.; Zhou, Y.; Deng, X.; Pan, J. Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China. PLoS ONE 2016, 11, e0155965. [Google Scholar] [CrossRef] [Green Version]
- Yao, N.; Zeng, Q.; Wang, Q. Seroepidemiology of diphtheria and pertussis in Chongqing, China: Serology-based evidence of Bordetella pertussis infection. Public Health 2018, 156, 60–66. [Google Scholar] [CrossRef]
- Zhang, Y.; Chen, Z.; Zhao, J.; Zhang, N.; Chen, N.; Zhang, J.; Li, S.; He, Q. Increased susceptibility to pertussis in adults at childbearing age as determined by comparative seroprevalence study, China 2010-2016. J. Infect. 2019, 79, 1–6. [Google Scholar] [CrossRef]
- Beijing Municipal Health Big Data and Policy Research Center. Compendium of Health Statistics. Available online: http://www.phic.org.cn/tjsj/wstjjb/ (accessed on 23 May 2022).
- Katfy, K.; Diawara, I.; Maaloum, F.; Aziz, S.; Guiso, N.; Fellah, H.; Slaoui, B.; Zerouali, K.; Belabbes, H.; Elmdaghri, N. Pertussis in infants, in their mothers and other contacts in Casablanca, Morocco. BMC Infect. Dis. 2020, 20, 43. [Google Scholar] [CrossRef]
- Winter, K.; Glaser, C.; Watt, J.; Harriman, K. Pertussis epidemic--California, 2014. MMWR Morb. Mortal. Wkly. Rep. 2014, 63, 1129–1132. [Google Scholar]
- European Centre for Disease Prevention and Control. Pertussis-Annual epidemiological report for 2016. Available online: https://www.ecdc.europa.eu/en/publications-data/pertussis-annual-epidemiological-report-2016 (accessed on 4 April 2022).
- Marshall, K.S.; Quinn, H.E.; Pillsbury, A.J.; Maguire, J.E.; Lucas, R.M.; Dey, A.; Beard, F.H.; Macartney, K.K.; McIntyre, P.B. Australian vaccine preventable disease epidemiological review series: Pertussis, 2013–2018. Commun. Dis. Intell. (2018) 2022, 46, 1–30. [Google Scholar] [CrossRef]
- Macina, D.; Evans, K.E. Bordetella pertussis in School-Age Children, Adolescents, and Adults: A Systematic Review of Epidemiology, Burden, and Mortality in Asia. Infect. Dis. Ther. 2021, 10, 1115–1140. [Google Scholar] [CrossRef]
- Macina, D.; Evans, K.E. Bordetella pertussis in School-Age Children, Adolescents and Adults: A Systematic Review of Epidemiology and Mortality in Europe. Infect. Dis. Ther. 2021, 10, 2071–2118. [Google Scholar] [CrossRef] [PubMed]
- Torzsa, P.; Devadiga, R.; Tafalla, M. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: Results of an epidemiological cross-sectional study. BMC Infect. Dis. 2017, 17, 242. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Conde-Glez, C.; Lazcano-Ponce, E.; Rojas, R.; DeAntonio, R.; Romano-Mazzotti, L.; Cervantes, Y.; Ortega-Barria, E. Seroprevalence of Bordetella pertussis in the Mexican population: A cross-sectional study. Epidemiol. Infect. 2014, 142, 706–713. [Google Scholar] [CrossRef] [Green Version]
- Echaniz-Aviles, G.; García-Cisneros, S.; Sánchez-Alemán, M.A.; Olamendi-Portugal, M.; Romero-Martinez, M.; Deantonio, R.; Cervantes-Apolinar, M.Y.; Ortega-Barria, E.; Cortes-Alcala, R.; Alpuche-Aranda, C.M. Estimating Bordetella pertussis seroprevalence in adolescents and young adults in Mexico using the 2012 National Health and Nutrition Survey (ENSANUT). Vaccine 2021, 39, 5839–5844. [Google Scholar] [CrossRef]
- Scott, S.; van der Sande, M.; Faye-Joof, T.; Mendy, M.; Sanneh, B.; Barry Jallow, F.; de Melker, H.; van der Klis, F.; van Gageldonk, P.; Mooi, F.; et al. Seroprevalence of pertussis in the Gambia: Evidence for continued circulation of Bordetella pertussis despite high vaccination rates. Pediatr. Infect. Dis. J. 2015, 34, 333–338. [Google Scholar] [CrossRef] [Green Version]
- Barkoff, A.M.; Mertsola, J.; Pierard, D.; Dalby, T.; Hoegh, S.V.; Guillot, S.; Stefanelli, P.; van Gent, M.; Berbers, G.; Vestrheim, D.; et al. Pertactin-deficient Bordetella pertussis isolates: Evidence of increased circulation in Europe, 1998 to 2015. Euro. Surveill. 2019, 24, 1700832. [Google Scholar] [CrossRef]
- Barkoff, A.M.; He, Q. Molecular Epidemiology of Bordetella pertussis. Adv. Exp. Med. Biol. 2019, 1183, 19–33. [Google Scholar] [CrossRef]
Year | Group | n | GMC (95% CI) (IU/mL) | Median (95% CI) (IU/mL) | ≥40 IU/mL | ≥100 IU/mL | ||
---|---|---|---|---|---|---|---|---|
n | Positive (%) | n | Positive (%) | |||||
2018 | Total | 503 | 3.82(3.52–4.14) | 3.27(2.99–3.71) | 9 | 1.79 | 2 | 0.40 |
Age | ||||||||
20~29 y | 252 | 4.28(3.82–4.81) | 3.67(3.14–4.24) | 5 | 1.98 | 1 | 0.40 | |
30~39 y | 251 | 3.40(3.04–3.80) | 2.94(2.50–3.50) 4 | 4 | 1.59 | 1 | 0.40 | |
Sex | ||||||||
Male | 276 | 3.61(3.24–4.03) | 3.08(2.73–3.41) | 6 | 2.17 | 1 | 0.36 | |
Female | 227 | 4.08(3.62–4.60) | 3.78(2.99–4.32) | 3 | 1.32 | 1 | 0.44 | |
2019 | Total | 735 | 3.81(3.55–4.09) | 3.24(3.01–3.51) | 15 | 2.04 | 1 | 0.14 |
Age | ||||||||
20~29 y | 327 | 3.78(3.38–4.22) | 3.12(2.81–3.51) | 8 | 2.45 | 1 | 0.31 | |
30~39 y | 408 | 3.84(3.51–4.21) | 3.35(3.01–3.81) | 7 | 1.72 | 0 | 0.00 | |
Sex | ||||||||
Male | 407 | 3.84(3.49–4.23) | 3.27(2.95–3.64) | 10 | 2.46 | 1 | 0.25 | |
Female | 328 | 3.78(3.40–4.19) | 3.18(2.88–3.76) | 5 | 1.52 | 0 | 0.00 | |
2020 | Total | 783 | 3.34(3.13–3.56) | 2.96(2.72–3.31) 2,3 | 13 | 1.66 | 1 | 0.13 |
Age | ||||||||
20~29 y | 347 | 3.31(3.00–3.65) | 2.97(2.64–3.39) | 5 | 1.44 | 1 | 0.29 | |
30~39 y | 436 | 3.63(3.09–3.66) | 2.96(2.59–3.45) | 8 | 1.83 | 0 | 0.00 | |
Sex | ||||||||
Male | 385 | 3.65(3.33–4.01) | 3.26(2.79–3.80) | 11 | 2.86 | 1 | 0.26 | |
Female | 398 | 3.06(2.81–3.33) | 2.78(2.43–3.10) 5 | 2 | 0.50 6 | 0 | 0.00 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chen, Z.; Pang, J.; Zhang, Y.; Ding, Y.; Chen, N.; Zhang, N.; He, Q. Seroprevalence of Pertussis in Adults at Childbearing Age Pre- and Post- COVID-19 in Beijing, China. Vaccines 2022, 10, 872. https://doi.org/10.3390/vaccines10060872
Chen Z, Pang J, Zhang Y, Ding Y, Chen N, Zhang N, He Q. Seroprevalence of Pertussis in Adults at Childbearing Age Pre- and Post- COVID-19 in Beijing, China. Vaccines. 2022; 10(6):872. https://doi.org/10.3390/vaccines10060872
Chicago/Turabian StyleChen, Zhiyun, Jie Pang, Yuxiao Zhang, Yiwei Ding, Ning Chen, Nan Zhang, and Qiushui He. 2022. "Seroprevalence of Pertussis in Adults at Childbearing Age Pre- and Post- COVID-19 in Beijing, China" Vaccines 10, no. 6: 872. https://doi.org/10.3390/vaccines10060872